The Chemours (CC) Company announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Chemours Chair Dawn Farrell Resigns for New Role
- Chemours, SRF Limited announce strategic agreements in India
- Chemours Company Positioned for Growth with Samsung Endorsement and 2PIC Commercialization
- Chemours Company Reports Q2 2025 Financial Results
- Chemours Company Reports Strong Q2 Amid Challenges